達仁堂(600329.SH):上半年淨利4.69億元,同比增加1.35%
格隆匯8月14日丨達仁堂(600329.SH)披露2022年半年度報吿,2022年上半年,在戰略調整,資源部署,渠道調動取得既定階段性目標的同時,公司各板塊特別是市場銷售板塊統籌當期的經營發展,爭分奪秒,堅守本職,有力保證了期間業績穩中有升。公司實現財務口徑營業收入37.75億元,同比增長3.69%,實現歸屬於母公司股東的淨利潤4.69億元,同比增加1.35%,其中自營利潤同比增加7.70%,完成了當期的產值和銷售任務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.